home / stock / onvo / onvo news

ONVO News and Press, Organovo Holdings Inc.

Stock Information
Company Name: Organovo Holdings Inc.
Stock Symbol: ONVO
Market: NASDAQ
Website: organovo.com
Menu
ONVO ONVO Quote ONVO Short ONVO News ONVO Articles ONVO Message Board
Get ONVO Alerts

News, Short Squeeze, Breakout and More Instantly...
ONVO - US Companies Moving the Markets, Morning edition
Tue, Jul 16, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Conduit Pharmaceuticals Inc. (CDT) rose 40.0% to $0.3361 on volume of 63,970,490 shares Yoshitsu Co. Ltd (TKLF) rose 64.0% to $0.5024 on volume of 62,618,792 shares Silo Pharma Inc. (SILO) rose 91.8% to $2.0522 on volume of 59,055,593...
ONVO - Organovo Highlights FXR314 Near Term Value Catalysts at Jones Trading Conference Strong Preclinical and Human Rationale for FXR314 in P2 2 Ulcerative Colitis

SAN DIEGO, July 16, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) including ulcerative colitis, today announced that Executive Chairman Keith Murphy presen...

ONVO - ONVO Stock Earnings: Organovo Holdings Beats EPS, Misses Revenue for Q4 2024

2024-06-03 11:52:53 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Organovo Holdings (NASDAQ: ONVO ) just reported results for the fourth quarter of 2024. Organovo Holdings reported earnings per share of -29 cents. This was above the anal...

ONVO - Organovo Data Presented at Digestive Disease Week (DDW2024) Demonstrating Potential for FXR314 as Combination Therapy with Tofacitinib for Inflammatory Bowel Disease

SAN DIEGO, May 21, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) including ulcerative colitis, today announces data from a poster presented at Digestive Di...
ONVO - Organovo to Present Data on FXR314 at Digestive Diseases Week (DDW2024)

SAN DIEGO, May 14, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq:ONVO), a clinical stage biotechnology company focused on developing novel treatment approaches in inflammatory bowel disease (IBD) including ulcerative colitis, today announces it will be presenting data on the Company&#x...

ONVO - Organovo Holdings, Inc. Announces Pricing of $5.25 Million Public Offering

SAN DIEGO, May 08, 2024 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (Nasdaq: ONVO) (“Organovo” or the “Company”), a clinical stage biotechnology company focused on developing novel treatment approaches based on demonstration of clinical promise in three-dimensional (3D...

ONVO - GME, ONVO and POAI among pre-market losers

2024-05-06 08:26:44 ET More on pre-market losers & stocks. GameStop: Approaching An Optimistic Fair Value But Not There Yet GameStop: Operations Are Stabilizing, But Expect More Pain To Come Predictive Oncology Inc. (POAI) Q4 2023 Earnings Call Transcript ...
ONVO - INVO, EZGO and WISA among pre-market losers

2024-04-18 08:15:07 ET Losers: Lithium Americas Corp LAC -24% on plans for 55M-share offering . NRX Pharmaceuticals NRXP -22% announces proposed underwritten public offering of common stock . Canaan CAN -22% files for $300M mixed shelf offering . Ic...

ONVO - INDO, ONVO and HUSA among pre-market losers

2024-04-16 08:28:48 ET More on pre-market losers & stocks. Financial information for Houston American Energy Financial information for Indonesia Energy Financial information for Organovo Holdings Compare metrics for HUSA to INDO, ONVO Read the f...

ONVO - US Companies Moving the Markets, Evening edition
Mon, Apr 15, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States PROSHARES TRUST (SQQQ) rose 5.1% to $11.44 on volume of 198,678,404 shares Trio Petroleum Corp. (TPET) rose 22.1% to $0.63 on volume of 179,140,668 shares Soligenix Inc. (SNGX) rose 21.7% to $0.47 on volume of 133,754,026 shares Sup...
Next 10